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Abstract	  
Due	  to	  the	  recent	  rise	  in	  antibiotic	  resistant	  pathogens,	  and	  the	  difficulties	  
surrounding	  the	  quest	  for	  new	  antibiotics,	  many	  researchers	  have	  started	  revisiting	  
antibiotic	  interactions	  in	  hopes	  of	  finding	  new	  treatment	  options.	  	  The	  primary	  outcome	  of	  
this	  project	  was	  to	  examine	  the	  efficacy	  of	  concomitant	  antibiotic	  use	  under	  varying	  
nutrient	  conditions,	  to	  identify	  variations	  in	  antibiotic	  interactions.	  	  Antibiotic	  interactions	  
were	  studied,	  utilizing	  E.	  coli	  as	  a	  model	  bacterial	  system,	  grown	  in	  four	  different	  media	  
types.	  	  E.	  coli	  cultures	  were	  treated	  with	  streptomycin,	  tobramycin,	  erythromycin,	  and	  
amikacin	  individually	  and	  in	  a	  pairwise	  fashion	  at	  varying	  doses.	  	  We	  found	  that	  at	  least	  
some	  antibiotic	  efficacies	  were	  dependent	  on	  the	  environmental	  nutrient	  conditions	  E.	  coli	  
was	  grown	  in,	  as	  the	  antibiotics	  were	  not	  equally	  effective	  in	  all	  media	  types.	  	  E.	  coli	  grown	  
in	  potato	  dextrose	  broth,	  in	  particular,	  showed	  extremely	  high	  tolerance	  to	  antibiotic	  
inhibition.	  	  In	  addition,	  we	  observed	  several	  variations	  in	  antibiotic	  interactions,	  depending	  
on	  the	  combination	  of	  antibiotics	  and	  environmental	  conditions	  utilized.	  	  It	  is	  predicted	  that	  
differences	  in	  available	  nutrients	  is	  the	  primary	  cause	  of	  the	  observed	  discrepancies	  in	  
antibiotic	  properties	  between	  media.	  	  The	  observation	  of	  changes	  in	  antibiotic	  efficacy	  
under	  different	  environmental	  and	  nutrient	  conditions	  has	  serious	  implications	  for	  use	  of	  
antibiotic	  combinations	  as	  drug	  treatments.	  	  Not	  all	  microenvironments	  within	  the	  human	  
body	  have	  identical	  nutrient	  make-­‐up.	  	  If	  the	  interactions	  antibiotics	  are	  reported	  to	  have	  in	  
one	  environmental	  condition	  change	  under	  another,	  reckless	  prescription	  of	  combinations	  
could	  lead	  to	  a	  serious	  adverse	  reaction.	  	  Thus,	  this	  is	  an	  important	  area	  for	  future	  in	  vitro	  
and	  in	  vivo	  research.	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Introduction	  
	   Antibiotic	  resistance	  has	  become	  a	  major	  issue	  in	  modern	  society.	  	  Contraction	  of	  
life	  threatening,	  multi-­‐drug	  resistant	  infections	  used	  to	  be	  limited	  to	  hospitals	  and,	  as	  such,	  
relatively	  contained.	  	  However,	  recently	  both	  methicillin-­‐resistant	  Staphylococcus	  aureus	  
(MRSA)	  and	  multi-­‐drug	  resistant	  tuberculosis	  (MDR-­‐TB)	  have	  been	  found	  in	  the	  general	  
community.	  	  Although	  these	  two	  strains,	  which	  exhibit	  the	  most	  complete	  resistance,	  are	  
still	  relatively	  rare,	  resistance	  genes	  themselves	  are	  quite	  common.	  	  Many	  pathogens	  
exhibit	  at	  least	  some	  level	  of	  resistance	  (Fernandes,	  2006).	  	  Additionally,	  resistance	  genes	  
are	  not	  specific	  to	  pathogens.	  	  One	  study,	  that	  surveyed	  a	  large	  collection	  of	  soil	  bacteria,	  
revealed	  a	  large	  and	  unexpected	  reservoir	  of	  resistance	  factors	  to	  all	  known	  antibiotics	  
(Cottarel	  &	  Wierzbowski,	  2007).	  	  This	  discovery	  was	  concerning	  due	  to	  the	  ease	  with	  which	  
horizontal	  gene	  transfer	  could	  lead	  to	  the	  sharing	  of	  these	  defense	  mechanisms	  (Davies	  &	  
Davies,	  2010).	  	  Some	  scientists	  fear	  humanity	  will	  soon	  be	  returning	  to	  the	  pre-­‐antibiotic	  
era,	  as	  the	  current	  antibiotics	  are	  rapidly	  becoming	  obsolete	  (Fernandes,	  2006;	  Davies	  &	  
Davies,	  2010).	  	  
	   During	  the	  Golden	  Age	  of	  antibiotics,	  these	  chemical	  weapons	  were	  discovered	  in	  
mass	  and	  medicine	  thought	  it	  had	  found	  its	  cure	  for	  bacterial	  infections.	  	  More	  than	  half	  of	  
the	  major	  antibacterial	  drug	  classes,	  such	  as	  aminoglycosides,	  cephalosporins,	  
glycopeptides,	  macrolides,	  tetracyclines,	  sulfonamides	  and	  penicillins	  were	  discovered	  at	  
that	  time	  (Amato	  et	  al.,	  2014,	  Fernandes,	  2006).	  	  With	  the	  exception	  of	  folic	  acid	  inhibitors,	  
the	  discovery	  of	  new	  antibiotics	  has	  virtually	  come	  to	  a	  halt	  in	  recent	  history.	  	  There	  are	  
several	  factors	  that	  have	  contributed	  to	  this	  stall.	  	  First	  of	  all,	  during	  the	  Golden	  Age,	  all	  of	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the	  easily	  identified	  antibiotic	  compounds	  were	  discovered.	  	  As	  such,	  the	  discovery	  of	  
completely	  new	  antibiotic	  compounds,	  with	  novel	  mechanisms,	  has	  become	  difficult	  and	  
time	  consuming.	  	  Researchers	  instead	  turned	  to	  chemically	  modifying	  and	  improving	  the	  
existing	  compounds.	  	  While	  this	  was	  highly	  effective	  for	  a	  time,	  new	  and	  inventive	  
modifications	  are	  increasingly	  hard	  to	  come	  by.	  	  Additionally,	  it	  is	  extremely	  difficult	  to	  get	  
antibiotics	  approved	  by	  regulatory	  agencies.	  	  These	  agencies	  have	  a	  low	  tolerance	  for	  
adverse	  side	  effects	  in	  antibiotics.	  	  In	  contrast,	  anti-­‐cancer	  medications	  often	  have	  severe	  
adverse	  side,	  but	  are	  more	  easily	  approved.	  	  It	  has	  been	  speculated	  that	  this	  discrepancy	  is	  
due	  to	  the	  fact	  that	  most	  bacterial	  infections	  are	  not	  life	  threatening	  and	  thus	  adverse	  side	  
effects	  are	  not	  tolerated	  as	  opposed	  to	  those	  in	  cancer	  treatment	  where	  it	  is	  apparent	  the	  
treatment	  is	  essential	  even	  if	  it	  is	  basically	  poison.	  	  Finally,	  large	  pharmaceutical	  companies	  
lack	  the	  motivation	  to	  pursue	  antibiotic	  research.	  	  There	  is	  little	  economic	  incentive	  for	  this	  
type	  of	  research.	  	  The	  research	  itself	  is	  expensive	  and	  lengthy.	  	  Additionally,	  the	  moment	  
the	  drug	  is	  approved	  and	  begins	  being	  used,	  resistance	  starts	  to	  evolve,	  which	  will	  
ultimately	  render	  the	  drug	  useless.	  	  When	  a	  new	  antibiotic	  is	  placed	  on	  the	  market,	  it	  is	  
often	  saved	  as	  a	  “last	  defense”	  against	  the	  already	  highly	  resistant	  bacteria,	  on	  which	  
nothing	  else	  will	  work.	  	  Doctors	  are	  told	  to	  use	  these	  precious	  drugs	  sparingly,	  and	  thus,	  
there	  are	  not	  enough	  profits	  made	  before	  patents	  expire	  to	  recuperate	  the	  costs	  invested	  
(Fernandes,	  2006).	  	  As	  such,	  researchers	  have	  turned	  their	  attentions	  back	  towards	  
antibiotics	  that	  are	  currently	  in	  circulation	  in	  hopes	  that	  better	  understanding,	  through	  
improved	  technologies,	  could	  be	  illuminating.	  





	   Under	  optimal	  conditions	  Escherichia	  coli	  cells	  can	  divide	  every	  20	  to	  30	  minutes.	  	  All	  
E.	  coli	  needs	  in	  order	  to	  maintain	  this	  level	  of	  rapid	  growth	  are	  some	  basic	  macro-­‐	  and	  
micro-­‐nutrients.	  	  Macronutrients	  are	  molecules	  that	  must	  be	  present	  in	  relatively	  high	  
concentrations	  for	  sustained	  bacterial	  growth.	  	  These	  macronutrients	  include	  sources	  of	  
carbon,	  nitrogen,	  phosphorus,	  hydrogen,	  oxygen	  and	  sulfur.	  	  These	  are	  the	  most	  basic	  
building	  blocks	  necessary	  for	  synthesis	  of	  carbohydrates,	  lipids,	  nucleic	  acids,	  and	  proteins.	  	  
Additionally	  several	  cations,	  such	  as	  K+,	  Mg2+,	  Ca2+,	  and	  Fe2+,	  are	  also	  considered	  
macronutrients	  and	  act	  as	  intercellular	  and	  extracellular	  signals	  as	  well	  as	  cofactors	  for	  
many	  enzymes.	  	  In	  contrast,	  only	  trace	  amounts	  of	  micronutrients,	  like	  cobalt,	  manganese,	  
nickel,	  zinc,	  molybdenum,	  and	  copper,	  are	  necessary	  for	  sustained	  bacterial	  growth.	  	  These	  
micronutrients	  often	  take	  on	  the	  role	  of	  enzyme	  cofactors.	  	  While	  this	  limited	  list	  of	  
ingredients	  is	  all	  it	  takes	  to	  grow	  E.	  coli,	  many	  bacteria	  require	  many	  more	  nutrients	  
provided	  for	  them	  and	  numerous	  species	  have	  adapted	  to	  their	  specific	  environment	  to	  
such	  a	  degree	  that	  scientists	  have	  yet	  to	  discover	  how	  to	  grow	  them	  in	  a	  laboratory	  setting	  
at	  all	  (Slonczewski	  &	  Foster,	  2011).	  	  Because	  of	  the	  rapid	  cellular	  growth	  and	  ease	  of	  use,	  E.	  
coli	  has	  been	  extensively	  studied	  as	  an	  experimental	  model	  for	  in	  vitro	  experiments	  
regarding	  the	  efficacy	  of	  antibiotics	  and	  was	  chosen	  as	  our	  model	  system	  for	  this	  body	  of	  
work.	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   Bacteria	  do	  not	  replicate	  at	  their	  fastest	  possible	  rate	  for	  their	  entire	  life	  cycle,	  not	  
even	  the	  highly	  prolific	  E.	  coli,	  but	  rather	  have	  various	  life	  stages	  marked	  by	  different	  rates	  
of	  population	  growth.	  	  The	  lag	  phase	  occurs	  when	  cells	  are	  first	  transferred	  from	  an	  old	  
culture	  to	  a	  new	  one.	  	  Bacteria	  have	  complex	  sensory	  mechanisms,	  which	  register	  and	  
process	  information	  from	  the	  environment	  such	  as,	  what	  nutrients	  are	  available,	  or	  what	  
toxins	  are	  present.	  	  This	  information	  is	  used	  to	  regulate	  gene	  expression	  accordingly,	  and	  
synthesize	  the	  components	  necessary	  to	  prepare	  for	  rapid	  growth.	  	  It	  would	  make	  sense	  
then	  for	  the	  rapid	  growth	  phase	  to	  follow,	  as	  it	  does	  in	  exponential	  phase.	  	  Exponential	  
phase	  is	  named	  for	  the	  exponential	  growth	  of	  the	  culture	  as	  each	  cell	  replicates	  at	  its	  
maximum	  rate.	  	  It	  is	  also	  the	  phase	  at	  which	  individual	  cells	  are	  at	  their	  largest	  to	  
accommodate	  all	  of	  the	  bulky	  machinery	  required	  for	  growth.	  	  As	  nutrients	  begin	  to	  become	  
scarce,	  because	  they	  have	  been	  mostly	  used	  up,	  and	  waste	  products	  begin	  building	  up,	  the	  
bacteria	  enter	  stationary	  phase.	  	  A	  fairly	  steady	  population	  density	  characterizes	  stationary	  
phase.	  	  In	  order	  to	  maintain	  this	  steady	  stationary	  phase,	  many	  bacteria	  initiate	  protective	  
genes	  to	  compensate	  for	  the	  increased	  risk	  of	  damage	  due	  to	  oxygen	  radicals	  and	  other	  
metabolic	  byproducts,	  some	  going	  so	  far	  as	  to	  sporulate	  or	  encyst.	  	  Finally	  the	  cells	  enter	  
death	  phase	  where	  cells	  begin	  to	  die	  from	  toxic	  byproduct	  buildup.	  	  Culture	  death,	  like	  
culture	  growth,	  happens	  on	  a	  logarithmic	  regression	  (Slonczewski	  &	  Foster,	  2011).	  	  For	  a	  
visual	  representation	  of	  bacterial	  growth	  view	  Figure	  1.	  	  Experiments	  looking	  at	  antibiotic	  
interactions	  for	  the	  body	  of	  work	  in	  this	  thesis	  focused	  on	  the	  exponential	  phase	  for	  E.	  coli,	  
to	  ensure	  inclusion	  of	  the	  time	  interval	  of	  maximal	  bacterial	  growth	  (Kacena,	  1999).	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Figure	  1:	  Theoretical	  model	  of	  bacterial	  growth	  curve	  (Komorniczak,	  2009).	  
Environmental	  Stressors	  
	  
Along	  with,	  and	  in	  addition	  to,	  the	  growth	  phases,	  many	  environmental	  factors	  have	  
considerable	  effects	  on	  bacterial	  growth.	  	  Temperature	  (Raghubeer	  &	  Matches,	  1990)	  and	  
pH	  (Gale	  &	  Epps,	  1945;	  as	  reviewed	  by	  Conner,	  1995)	  have	  been	  shown	  to	  play	  a	  significant	  
role	  in	  both	  enzyme	  activity	  and	  overall	  cellular	  growth.	  	  Osmolarity	  (Record	  et	  al.,	  1998)	  
and	  nutrient	  limitation	  (Slonczewski	  &	  Foster,	  2011)	  lead	  to	  changes	  in	  cellular	  morphology	  
and	  physiology,	  such	  as	  changes	  in	  membrane	  permeability	  and	  water	  influx	  and	  efflux,	  
decreases	  in	  size,	  and	  the	  synthesis	  of	  distinct	  stress	  resistant	  enzymes.	  	  Each	  of	  these	  
responses	  takes	  energy	  and	  resources	  away	  from	  cellular	  growth.	  	  Access	  to	  oxygen	  can	  
affect	  which	  catabolic	  pathways	  bacteria	  can	  use,	  further	  affecting	  the	  rate	  and	  efficacy	  of	  
catabolic	  activity	  (White,	  2007).	  	  Our	  experiments	  utilized	  previously	  published	  and	  studied	  
temperature	  and	  pH	  data	  (Yeh	  et	  al.,	  2006)	  and	  manipulated	  nutrition.	  	  Finally,	  destructive	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chemicals,	  such	  as	  antibiotics	  synthesized	  by	  competing	  microbes	  or	  reactive	  oxidative	  
species	  that	  are	  the	  by-­‐product	  of	  metabolism,	  reap	  further	  havoc	  on	  bacterial	  growth.	  	  
Reactive	  oxidative	  species	  damage	  DNA,	  while	  antibiotics	  are	  capable	  of	  disrupting	  cell	  wall	  
synthesis,	  protein	  synthesis,	  DNA	  translation,	  and	  transcription,	  interfering	  with	  membrane	  
permeability,	  and	  inhibiting	  essential	  enzymes	  (as	  reviewed	  by	  Conner,	  1995,	  White,	  2007).	  
These	  environmental	  factors	  activate	  several	  stress	  responses	  bacteria	  have	  evolved	  
to	  cope	  with	  environmental	  stress,	  for	  example,	  the	  SOS,	  TAG,	  and	  SR	  responses.	  	  The	  SOS	  
response	  is	  triggered	  by	  DNA	  damage	  or	  DNA	  replication	  inhibition.	  	  It	  induces	  the	  
transcription	  of	  over	  20	  unlinked	  genes,	  including:	  DNA	  reparatory	  genes,	  genes	  that	  stall	  
cell	  division,	  and	  translesion	  synthesis	  genes,	  that	  allow	  replication	  to	  skip	  damaged	  
sections	  (White,	  2007).	  	  The	  TAG	  response	  is	  activated	  by	  changes	  in	  cellular	  carbon	  fluxes	  
and	  triggers	  the	  accumulation	  of	  the	  lipid	  triacylglycerol	  in	  preparation	  for	  a	  long	  period	  of	  
inactivity	  (Sedwick,	  2011;	  White,	  2007).	  	  This	  long	  period	  of	  inactivity	  is	  characterized	  by	  
little	  to	  no	  growth,	  immensely	  slowed	  metabolic	  rate	  and	  increased	  antibiotic	  resistance	  
(Baek	  et	  al.,	  2015).	  	  The	  stringent	  response	  (SR)	  is	  induced	  by	  guanosine	  tetraphosphate	  
(ppGpp)	  and	  guanosine	  pentaphosphate	  (pppGpp)	  and	  is	  a	  common	  bacterial	  response	  to	  
carbon,	  amino	  acid,	  and	  iron	  starvation	  (White,	  2007;	  Nguyen	  et	  al.	  2011).	  	  This	  starvation	  
response	  causes	  the	  cell	  to	  reallocate	  cellular	  resources	  and	  halts	  the	  synthesis	  of	  DNA,	  
stable	  RNA,	  ribosomal	  proteins	  and	  membrane	  components	  in	  favor	  of	  producing	  factors	  
crucial	  for	  stress	  resistance,	  glycolysis,	  and	  amino	  acid	  synthesis	  (Dalebroux	  &	  Swanson,	  
2012).	  	  The	  large	  changes	  in	  transcription	  profile	  caused	  by	  the	  stringent	  response,	  just	  as	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those	  of	  the	  SOS,	  TAG,	  and	  indole	  response,	  lead	  to	  a	  significant	  increase	  in	  antibiotic	  and	  
other	  stressor	  tolerance	  (Nguyen	  et	  al.,	  2011;	  Penesyan	  et	  al.,	  2015).	  	  	  
Metabolism	  
	   Every	  living	  organism	  has	  the	  ability	  to	  breakdown	  molecules	  it	  absorbs	  from	  its	  
environment	  into	  smaller	  components.	  	  This	  process,	  called	  catabolism,	  produces	  the	  
building	  blocks	  necessary	  to	  rebuild	  macromolecules	  and	  releases	  energy	  that	  can	  be	  
harnessed	  for	  cellular	  use.	  	  Anabolism	  then	  consists	  of	  all	  of	  the	  consumption	  of	  that	  energy	  
in	  order	  to	  rebuild	  macromolecules	  essential	  to	  the	  survival	  and	  growth	  of	  the	  organism.	  	  
There	  are	  three	  major	  nutrient	  groups:	  carbohydrates,	  lipids,	  and	  proteins.	  	  Each	  of	  these	  
nutrients	  is	  made	  up	  of	  different	  components	  and	  as	  such	  need	  different	  pathways	  for	  
breakdown.	  	  Additionally,	  breakdown	  of	  the	  individual	  monomers	  themselves	  differs	  
greatly.	  	  Thus,	  bacterial	  metabolism	  is	  a	  highly	  dynamic	  system	  of	  anabolic	  and	  catabolic	  
pathways	  highly	  dependent	  on	  nutrients	  found	  in	  the	  environment.	  
	   Carbohydrate,	  and	  particularly	  sugar	  breakdown	  is	  perhaps	  the	  simplest	  and	  most	  
studied	  catabolic	  pathway.	  	  When	  glucose	  enters	  the	  cell,	  it	  will	  be	  broken	  down	  by	  one	  of	  
three	  different	  central	  metabolic	  pathways.	  	  Two	  of	  these	  pathways,	  glycolysis	  and	  the	  
pentose	  phosphate	  pathway	  (PPP),	  can	  be	  found	  in	  both	  prokaryotic	  and	  eukaryotic	  cells,	  
but	  the	  third,	  the	  Entner	  –	  Doudoroff	  pathway	  (ED)	  is	  isolated	  to	  prokaryotes.	  	  Each	  of	  these	  
pathways	  will	  ultimately	  break	  the	  glucose	  down	  into	  a	  three-­‐carbon	  modified	  sugar	  called	  
pyruvate;	  however,	  their	  mechanisms	  differ	  slightly.	  	  Glycolysis	  produces	  two	  pyruvate,	  two	  
ATP	  energy	  molecules,	  and	  2	  NADH	  electron	  carrier	  molecules.	  	  Intermediate	  products	  of	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glycolysis	  are	  also	  important	  precursor	  metabolites	  for	  many	  other	  pathways	  including	  
polysaccharides,	  pentose	  phosphates,	  aromatic	  amino	  acids,	  amino	  sugars,	  phospholipids,	  
and	  the	  amino	  acids	  glycine,	  serine,	  and	  cysteine.	  	  PPP	  produces	  phosphoglyceraldehyde,	  
CO2	  and	  the	  electron	  carrier	  NADPH.	  	  NADPH	  is	  an	  important	  source	  of	  electrons	  for	  
biosynthesis	  and	  phosphoglyceraldehyde	  can	  either	  re-­‐enter	  the	  glycolytic	  pathway	  to	  end	  
up	  as	  pyruvate	  or	  be	  used	  as	  a	  precursor	  for	  nucleic	  acids.	  	  ED	  catalyzes	  the	  same	  overall	  
reaction	  as	  glycolysis	  but	  produces	  only	  one	  ATP	  and	  one	  NADH	  plus	  one	  NADPH.	  	  While	  ED	  
produces	  less	  cellular	  energy,	  it	  is	  more	  effective	  at	  breaking	  down	  some	  sugars	  and	  
particularly	  aldonic	  acids	  than	  its	  counterparts.	  	  Some	  bacteria	  only	  use	  one	  of	  these	  
pathways,	  while	  others	  use	  all	  three	  under	  varying	  circumstances.	  	  This	  allows	  the	  
bacterium	  to	  have	  increased	  flexibility	  when	  responding	  to	  changes	  in	  environmental	  
conditions	  (White,	  2007).	  	  	  
Pyruvate	  produced	  from	  these	  central	  catalytic	  pathways	  can	  go	  down	  several	  paths	  
from	  here.	  	  In	  the	  presence	  of	  oxygen,	  pyruvate	  will	  go	  through	  further	  oxidation	  in	  the	  
Citric	  Acid	  Cycle,	  where	  more	  electron	  transport	  molecules	  will	  be	  produced.	  	  If	  energy	  is	  
plentiful,	  pyruvate	  would	  be	  tagged	  for	  storage	  and	  undergo	  gluconeogenesis.	  	  If	  energy	  is	  
needed,	  and	  oxygen	  is	  present,	  pyruvate	  will	  go	  through	  further	  oxidation	  in	  the	  Citric	  Acid	  
Cycle,	  where	  more	  electron	  transport	  molecules	  will	  be	  produced.	  	  Electron	  transport	  
molecules	  will	  carry	  their	  packages	  to	  the	  electron	  transport	  chain	  of	  oxidative	  
phosphorylation	  to	  produce	  ATP.	  	  Finally,	  if	  no	  oxygen	  is	  present	  pyruvate	  will	  be	  fermented	  
in	  order	  to	  regenerate	  oxidized	  electron	  carrying	  molecules	  NAD+	  and	  NADP-­‐	  so	  that	  glucose	  
breakdown	  can	  continue	  to	  occur	  (Slonczewski	  &	  Foster,	  2011).	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If	  the	  steps	  listed	  above	  were	  not	  already	  complicated	  enough,	  complex	  
carbohydrates	  must	  undergo	  steps	  prior	  to	  the	  central	  catabolic	  pathways	  in	  order	  to	  break	  
down	  polymers	  into	  monomers	  and	  proteins	  and	  lipids	  have	  their	  own	  complex	  catabolic	  
pathways.	  	  The	  overall	  result	  is	  a	  highly	  regulated	  web	  of	  metabolic	  processes	  responsible	  
for	  the	  breakdown	  of	  every	  nutrient	  absorbed	  and	  the	  building	  of	  every	  macromolecule	  
essential	  for	  bacterial	  survival	  and	  growth	  (Slonczewski	  &	  Foster,	  2011).	  	  Metabolism	  is	  an	  
important	  consideration	  for	  this	  body	  of	  research,	  as	  it	  is	  a	  primary	  effector	  of	  various	  
bacterial	  physiological	  traits.	  	  We	  varied	  our	  media,	  and	  nutrient	  availability,	  to	  determine	  
what	  effect	  nutrient	  availability,	  and	  the	  resulting	  metabolic	  processes	  these	  trigger,	  has	  on	  
bacterial	  tolerance	  to	  antibiotics.	  	  
The	  Bacterial	  Ribosome	  
	  
Figure	  2:	  Bacterial	  Ribosome	  drawn	  by	  David	  Goodsell	  from	  PDB	  files	  2wdk	  and	  2wdl.	  	  Small	  
(30S)	  subunit	  in	  front	  (green)	  and	  large	  (50S)	  subunit	  behind	  (blue)	  (Goodsell,	  2010).	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   Protein	  synthesis	  occurs	  at	  the	  ribosome,	  which	  functions	  as	  the	  GTP-­‐powered	  
machinery	  that	  converts	  genetic	  material	  into	  polypeptide	  chains.	  	  Ribosomes	  are	  perhaps	  
the	  most	  primitive	  specialized	  organelle	  and	  are	  conserved	  from	  prokaryotes	  to	  eukaryotes.	  	  
They	  can	  be	  found	  free-­‐floating	  in	  the	  cytosol	  or	  embedded	  in	  the	  endoplasmic	  reticulum	  of	  
eukaryotic	  cells	  (Slonczewski	  &	  Foster,	  2011).	  	  Single-­‐stranded	  messenger	  RNA	  (mRNA)	  
carries	  the	  genetic	  template	  for	  proteins	  to	  the	  ribosome,	  where	  tRNA	  molecules	  are	  used	  
to	  translate	  the	  nucleotides	  into	  an	  amino	  acid	  sequence.	  	  tRNA	  molecules	  are	  L-­‐shaped	  and	  
mostly	  double	  stranded;	  however,	  the	  anticodon	  loop	  and	  the	  3’	  end,	  the	  functional	  sites,	  
are	  single	  stranded.	  	  This	  allows	  the	  anticodon	  loops	  to	  associate	  with	  the	  mRNA	  threaded	  
through	  the	  small	  subunit	  and	  the	  3’	  ends	  to	  interact	  with	  amino	  acids,	  peptides,	  and	  the	  
large	  subunit.	  	  The	  ribosome	  has	  three	  tRNA	  binding	  sites	  in	  the	  peptidyl-­‐transferase	  center	  
(PTC):	  the	  aminoacyl-­‐	  (A),	  the	  peptidyl-­‐	  (P),	  and	  the	  exit-­‐	  (E)	  sites.	  	  Each	  elongation	  cycle	  is	  
made	  up	  of	  one	  decoding,	  one	  forming	  of	  the	  peptide	  bond,	  and	  one	  release	  of	  deacylated	  
tRNA	  step.	  	  These	  steps	  follow	  a	  tRNA	  as	  it	  advances,	  along	  with	  the	  mRNA	  it	  is	  bound	  to,	  
from	  the	  A	  to	  the	  P	  to	  the	  E	  site	  (as	  reviewed	  by	  Yonath,	  2005).	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Figure	  3:	  Computer	  rendered	  representation	  of	  the	  bacterial	  ribosome	  activation	  complex	  
with	  important	  features	  labeled.	  	  Yellow	  represents	  the	  30S	  ribosomal	  subunit,	  green	  
represents	  the	  50S	  subunit.	  	  mRNA	  is	  represented	  by	  orange.	  	  A	  and	  P	  sites	  labeled	  purple	  
and	  green	  respectively.	  	  Elongating	  polypeptide	  emerging	  through	  protein	  exit	  tunnel	  in	  50S	  
subunit.	  	  Image	  created	  by	  J.	  Lorsch	  from	  the	  work	  of	  Cate,	  J.	  H.	  et	  al.	  
	   The	  bacterial	  ribosome	  has	  RNA	  and	  protein	  elements.	  	  Long	  RNA	  chains	  make	  up	  
approximately	  two	  thirds	  of	  the	  ribosome’s	  mass	  and	  wrap	  around	  many	  different	  protein	  
components.	  	  All	  ribosomes	  have	  two	  subunits,	  a	  large	  subunit	  and	  a	  small	  subunit.	  	  In	  
eukaryotic	  ribosomes	  these	  are	  the	  60S	  and	  40S	  subunits	  respectively.	  	  Bacterial	  ribosomes	  
are	  slightly	  smaller	  and	  instead	  have	  50S	  and	  30S	  subunits.	  	  The	  50S	  ribosomal	  subunit	  has	  a	  
molecular	  weight	  of	  1.45	  MDa	  and	  contains	  two	  RNA	  chains	  plus	  31	  to	  35	  proteins.	  	  These	  
two	  RNA	  chains,	  23S	  and	  5S,	  contain	  approximately	  3000	  nucleotides	  total.	  	  The	  protein	  exit	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tunnel	  and	  PTC	  are	  important	  features	  of	  the	  large	  subunit.	  	  Two	  of	  the	  main	  differences	  
essential	  for	  antibiotic	  binding	  selectivity	  between	  the	  50S	  ribosomal	  subunit	  and	  the	  60S	  
ribosomal	  subunit	  consist	  of	  single	  nucleotide	  switches	  from	  adenine	  in	  prokaryotes	  to	  
guanine	  in	  eukaryotes.	  	  The	  decreased	  hydrogen	  bonding	  capacity	  of	  guanine	  makes	  
antibiotic	  binding	  unfavorable	  in	  eukaryotes.	  	  The	  30S	  ribosomal	  subunit	  is	  composed	  of	  
only	  one	  RNA	  chain	  and	  between	  20	  and	  21	  proteins.	  	  These	  proteins,	  plus	  the	  approximate	  
1500	  nucleotides	  that	  make	  up	  the	  16S	  RNA	  chain,	  give	  the	  small	  subunit	  a	  molecular	  
weight	  of	  0.85	  MDa.	  	  The	  decoding	  center	  is	  the	  central	  feature	  of	  the	  small	  subunit,	  making	  
it	  responsible	  for	  translation	  fidelity.	  	  The	  50S	  and	  30S	  subunits	  are	  held	  together	  in	  an	  
active	  ribosomal	  complex	  by	  flexible	  components	  of	  both	  subunits,	  which	  form	  intersubunit	  
bridges,	  as	  well	  as	  by	  tRNA	  molecules	  that	  associate	  with	  both	  subunits	  during	  protein	  
synthesis	  (as	  reviewed	  by	  Yonath,	  2005).	  
	   Each	  of	  the	  important	  features	  of	  the	  bacterial	  ribosome	  is	  a	  potential	  area	  of	  attack	  
for	  antibiotics.	  	  These	  targets	  include:	  the	  decoding	  site,	  the	  PTC,	  the	  protein	  exit	  tunnel,	  
and	  the	  mRNA	  threading	  and	  advancement	  machinery.	  	  The	  decoding	  center	  has	  two	  
prominent	  features,	  the	  upper	  portion	  of	  helix	  H44	  and	  helix	  H27.	  	  The	  upper	  region	  of	  H44	  
is	  responsible	  for	  almost	  all	  of	  the	  intersubunit	  contact	  in	  the	  assembled	  ribosome.	  	  If	  a	  
compound	  other	  than	  the	  50S	  subunit	  bound	  to	  H44,	  it	  would	  block	  assembly	  of	  a	  
functional	  ribosome.	  	  H27,	  on	  the	  other	  hand,	  is	  a	  mobile	  component	  of	  the	  ribosome.	  	  It	  is	  
referred	  to	  as	  the	  switch	  helix,	  because	  it	  undergoes	  conformational	  changes	  that	  play	  a	  
role	  in	  tRNA	  and	  mRNA	  progression.	  	  The	  ribosomal	  catalytic	  site,	  containing	  the	  PTC,	  is	  
similarly	  important	  for	  tRNA	  and	  mRNA	  progression.	  	  Both	  sideways	  and	  rotary	  motions	  are	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necessary	  for	  translocation	  within	  the	  catalytic	  site,	  and	  as	  such,	  the	  delicate	  machinery	  can	  
easily	  be	  disrupted.	  	  In	  addition,	  it	  is	  also	  the	  site	  of	  peptide-­‐bond	  formation.	  	  If	  any	  
substrate	  binding	  is	  inhibited,	  peptide	  synthesis	  would	  fail.	  	  The	  exit	  tunnel	  is	  located	  below	  
the	  PTC	  and	  spans	  the	  entire	  large	  subunit.	  	  It	  used	  to	  be	  thought	  of	  as	  a	  stationary	  and	  
passive	  aspect	  of	  the	  ribosome;	  however,	  recent	  data	  suggests	  it	  is	  a	  dynamic	  participant	  
contributing	  to	  elongation	  discrimination	  and	  protein	  folding	  (as	  reviewed	  by	  Yonath,	  2005).	  
Protein	  Synthesis	  Inhibitors	  
	  
Figure	  4:	  Chemical	  structure	  of	  A:	  streptomycin,	  B:	  tobramycin,	  C:	  erythromycin,	  and	  D:	  
amikacin.	  
The	  antibiotics	  studied	  in	  this	  project	  included	  streptomycin,	  tobramycin,	  
erythromycin,	  and	  amikacin	  (Figure	  4).	  	  Previously	  published	  literature	  implicates	  inhibition	  
of	  protein	  synthesis	  as	  a	  possible	  contributing	  factor	  to	  antibiotic	  tolerance	  (Nguyen	  et	  al.,	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2011;	  Bernier	  et	  al.,	  2015;	  Penesyan	  et	  al.,	  2015;	  Prax	  &	  Bertram,	  2014;	  Cho	  et	  al,	  2014;	  
Amato	  et	  al.,	  2014).	  	  This	  was	  demonstrated	  by	  the	  tolerance	  induced	  by	  the	  lack	  of	  certain	  
essential	  amino	  acids	  (Nguyen	  et	  al.,	  2011;	  Bernier	  et	  al.,	  2015),	  the	  tolerance	  displayed	  by	  
auxotrophs	  (Bernier	  et	  al.,	  2015)	  and	  the	  tolerance	  associated	  with	  the	  persister	  phenotype,	  
which	  is	  believed	  to	  be	  induced	  by	  protein	  synthesis	  inhibition	  (Penesyan	  et	  al.	  2015;	  Prax	  &	  
Bertram,	  2014;	  Cho	  et	  al,	  2014;	  Amato	  et	  al.,	  2014).	  	  Due	  to	  this	  overlap	  in	  protein	  synthesis	  
inhibition,	  nutrient	  starvation,	  and	  tolerance,	  antibiotics	  targeting	  the	  ribosome	  and	  protein	  
synthesis	  became	  the	  focus	  of	  this	  study.	  	  Specifically,	  streptomycin,	  tobramycin,	  and	  
erythromycin	  were	  chosen	  for	  their	  commonality	  and	  amikacin	  for	  its	  relatively	  recent	  
introduction	  to	  the	  market.	  	  
Protein	  synthesis	  inhibitors	  have	  many	  modes	  of	  action	  including:	  interference	  with	  
proper	  coding,	  tRNA	  binding	  at	  the	  decoding	  center	  or	  PTC,	  minimization	  of	  ribosomal	  
mobility,	  and	  blockage	  of	  the	  protein	  exit	  tunnel.	  	  Streptomycin,	  tobramycin	  and	  amikacin	  
are	  aminoglycoside	  antibiotics.	  	  These	  bactericidal	  antibiotics	  contain	  a	  cyclohexane	  ring	  
and	  amino	  sugars	  (Slonczewski	  &	  Foster,	  2011;	  as	  reviewed	  by	  Yonath,	  2005).	  	  At	  high	  
concentrations,	  they	  bind	  irreversibly	  to	  a	  single	  amino	  acid	  of	  protein	  S12	  in	  the	  30S-­‐
mRNA-­‐tRNA	  initiation	  complex	  (KEGG	  drug,	  2016)	  preventing	  binding	  of	  the	  50S	  subunit	  
(Slonczewski	  &	  Foster,	  2011).	  	  This	  leads	  to	  a	  total	  shut	  down	  of	  translation	  and	  cellular	  
growth.	  	  In	  addition,	  at	  low	  concentrations,	  streptomycin	  and	  amikacin	  bind	  to	  the	  four	  
nucleotides	  of	  16S	  rRNA	  that	  forms	  part	  of	  the	  decoding	  A	  site	  (Slonczewski	  &	  Foster,	  2011;	  
KEGG	  Drug,	  2016).	  	  This	  causes	  translation	  to	  become	  “sloppy”	  with	  lots	  of	  mistranslated	  
protein	  sequences.	  	  These	  mistranslated	  polypeptides	  are	  often	  toxic	  to	  the	  cell.	  	  Amino	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acid	  binding	  sites	  are	  unique	  to	  prokaryotes	  due	  to	  just	  two	  A	  to	  G	  differences	  in	  ribosomal	  
DNA	  sequence	  between	  prokaryotes	  and	  eukaryotes	  (as	  reviewed	  by	  Yonath,	  2005).	  
Tobramycin	  has	  also	  been	  seen	  to	  destabilize	  the	  bacterial	  membrane	  (KEGG	  Drug).	  	  
Erythromycin	  on	  the	  other	  hand	  is	  a	  macrolide	  antibiotic	  and	  targets	  the	  50S	  subunit.	  	  These	  
antibiotics	  have	  large	  lactone	  rings	  of	  12-­‐22	  carbon	  atoms.	  	  They	  bind	  to	  the	  protein	  L15	  
and	  23S	  rRNA	  in	  the	  peptidyltransferase	  cavity	  which	  triggers	  release	  of	  peptidyl-­‐tRNA	  from	  
the	  P	  site	  (KEGG	  Drug,	  as	  reviewed	  by	  Yonath,	  2005).	  	  This	  ultimately	  prevents	  peptide	  bond	  
formation,	  protein	  synthesis,	  and	  cell	  growth	  or	  replication	  (Slonczewski	  &	  Foster,	  2011;	  as	  
reviewed	  by	  Yonath,	  2005).	  
Antibiotic	  Interactions	  
	  
There	  are	  three	  basic	  drug	  interactions:	  additive,	  synergistic,	  and	  antagonistic.	  	  In	  
essence	  an	  additive	  interaction	  is	  no	  interaction.	  	  It	  occurs	  when	  the	  effects	  of	  two	  drugs	  
used	  together	  is	  equally	  effective	  as	  the	  sum	  of	  the	  effectiveness	  of	  using	  both	  drugs	  alone.	  	  
A	  synergistic	  interaction	  is	  when	  two	  drugs	  used	  together	  have	  a	  larger	  than	  additive	  effect.	  	  
Finally,	  an	  antagonistic	  interaction	  is	  when	  the	  combination	  yields	  a	  smaller	  than	  additive	  
effect	  (Yeh	  et	  al.,	  2006).	  	  There	  are	  two	  subclasses	  of	  antagonistic	  interactions:	  antagonistic	  
buffering,	  when	  one	  drug	  masks	  the	  effect	  of	  the	  other,	  and	  antagonistic	  suppression,	  when	  
one	  drug	  counteracts	  the	  effects	  of	  the	  other	  leading	  to	  a	  higher	  growth	  rate	  than	  at	  least	  
one	  of	  them	  alone	  (Yeh	  et	  al.,	  2006;	  Yin	  et	  al.,	  2014).	  	  The	  current	  dominant	  hypothesis	  
underlying	  synergy	  is	  that	  synergistic	  pairs	  tend	  to	  have	  targets	  that	  are	  neighbors	  in	  
underlying	  biological	  networks,	  for	  example	  successive	  steps	  in	  the	  same	  pathway	  or	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components	  in	  two	  separate	  pathways	  that	  eventually	  contribute	  to	  the	  same	  end-­‐product	  
(Yin	  et	  al.	  2014;	  Gonzales	  et	  al.	  2015;	  Black,	  1962).	  	  The	  antibiotic	  combinations	  I	  explored	  
have	  the	  following	  published	  interactions	  in	  Lysogeny	  Broth	  media:	  synergistic	  between	  
streptomycin	  and	  tobramycin,	  streptomycin	  and	  amikacin,	  and	  tobramycin	  and	  amikacin;	  
additive	  interactions	  between	  erythromycin	  and	  tobramycin	  as	  well	  as	  erythromycin	  and	  
amikacin;	  and	  an	  antagonistic	  suppressive	  relationship	  between	  streptomycin	  and	  
erythromycin	  (Yeh	  et	  al.,	  2006).	  
Due	  to	  the	  recent	  rise	  in	  antibiotic	  resistant	  pathogens	  (Fernandes,	  2006;	  Davies	  &	  
Davies,	  2010)	  and	  the	  many	  issues	  surrounding	  the	  quest	  for	  new	  antibiotics	  (Fernandes,	  
2006),	  many	  scientists	  have	  started	  revisiting	  antibiotic	  interactions	  in	  hopes	  of	  finding	  new	  
treatment	  options.	  	  Synergistic	  antibiotic	  combinations,	  in	  particular,	  have	  clinical	  value	  as	  
they	  allow	  for	  a	  stronger	  inhibitory	  effect	  at	  lower	  dosages	  when	  compared	  with	  single	  
drugs	  (Mitosch	  &	  Bollenbach,	  2014).	  	  One	  study	  achieved	  great	  success	  treating	  highly	  
antibiotic	  resistant	  and	  lethal	  MRSA	  with	  a	  triple	  drug	  combination	  containing:	  cabapenems,	  
penicillins	  and	  β-­‐lactamase	  inhibitors	  (Gonzales	  et	  al.,	  2015).	  	  Despite	  the	  success	  of	  such	  
regimens,	  many	  are	  wary	  of	  their	  effects	  on	  resistance	  evolution.	  	  Several	  studies	  show	  a	  
correlation	  between	  rate	  of	  resistance	  adaptation	  and	  the	  degree	  of	  synergism	  between	  
individual	  antibiotics	  (Mitosch	  &	  Mollenback,	  2014;	  Hegreness	  et	  al.,	  2008).	  	  Other	  studies	  
are	  more	  optimistic	  and	  rely	  on	  the	  logic	  that	  inhibiting	  multiple	  targets,	  despite	  the	  
interaction,	  might	  delay	  resistance	  evolution,	  as	  it	  is	  harder	  to	  accumulate	  mutations	  for	  
multiple	  targets	  rapidly	  (Cottarel	  &	  Wierzbowski,	  2007).	  	  Under	  the	  same	  logic,	  antagonistic	  
interactions	  are	  currently	  being	  looked	  at	  as	  a	  promising	  mechanism	  to	  delay	  or	  even	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reverse	  resistance	  evolution.	  	  Two	  studies,	  performed	  by	  Ocampo	  et	  al.	  and	  Yin	  et	  al.	  in	  
2014,	  found	  that	  antagonism	  between	  antibiotics	  seems	  to	  delay	  the	  emergence	  of	  
resistance	  in	  a	  lab	  setting	  and	  one	  study,	  performed	  by	  Chait	  et	  al.	  in	  2007,	  showed	  that	  it	  
could	  even	  help	  reverse	  the	  resistance	  that	  currently	  exists	  by	  selecting	  for	  the	  non-­‐
resistant	  population.	  	  Further	  research	  in	  vitro	  and	  in	  vivo	  and	  delineation	  of	  optimal	  
concomitant	  antibiotic	  use	  could	  become	  essential	  for	  clinical	  practice,	  particularly	  with	  the	  
antibiotics	  studied	  here.	  	  These	  antibiotics	  are	  efficacious,	  all	  of	  these	  antibiotics	  are	  
available,	  commonly	  utilized,	  and	  approved	  for	  treatment	  for	  bacterial	  infections.	  	  Thus,	  
research	  in	  multiple	  antibiotic	  interactions	  may	  have	  a	  significant	  clinical	  impact,	  and	  may	  
improve	  and	  optimize	  patient	  care	  for	  difficult-­‐to-­‐treat	  infections.	  	  	  
Our	  Study	  
Changes	  in	  antibiotic	  interaction	  could	  have	  large	  implications	  in	  the	  clinical	  setting.	  	  
For	  example,	  if	  studies	  currently	  being	  run	  in	  LB	  provide	  clear	  indication	  of	  possibly	  
promising	  treatment	  options,	  it	  would	  be	  important	  to	  know	  these	  interactions	  are	  
consistent	  across	  all	  environments.	  	  The	  only	  way	  to	  better	  understand	  these	  interactions	  is	  
to	  start	  changing	  factors.	  	  Any	  of	  the	  environmental	  factors	  that	  affect	  cellular	  metabolism	  
and	  growth	  could	  be	  studied,	  but	  our	  study	  focuses	  on	  changes	  in	  nutrient	  availability	  by	  
growing	  E.	  coli	  in	  various	  growth	  media.	  
Lysogeny	  broth,	  or	  LB,	  media	  is	  a	  traditionally	  and	  commonly	  used	  media	  in	  which	  to	  
study	  E.	  coli.	  	  This	  is	  partially	  due	  to	  the	  fact	  that	  LB	  is	  a	  convenient	  media	  where	  E.	  coli	  
grows	  consistently.	  	  Additionally,	  it	  is	  such	  a	  common	  E.	  coli	  growth	  media	  that	  it	  provides	  a	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direct	  link	  for	  comparison	  purposes	  across	  literature.	  	  However,	  it	  is	  also	  a	  rather	  arbitrary	  
choice	  of	  study	  medium,	  particularly	  when	  you	  consider	  much	  of	  this	  research	  is	  intended	  
for	  use	  in	  the	  human	  body.	  	  LB	  media’s	  composition	  differs	  from	  that	  of	  human	  tissues,	  for	  
example	  blood,	  where	  bacteria	  are	  likely	  to	  cause	  infection.	  	  It	  is	  understood	  that	  factors	  
such	  as	  pH,	  nutrient	  availability,	  salt,	  etc.	  cause	  significant	  changes	  in	  bacterial	  metabolism	  
and	  growth.	  	  These	  changes	  in	  turn	  can	  affect	  antibiotic	  efficacy.	  	  Thus	  we	  hypothesize	  
interactions	  may	  also	  be	  affected	  by	  changes	  in	  environmental	  conditions.	  	  	  
Media	  
	   Lysogeny	  broth	  (LB)	  has	  traditionally	  been	  used	  to	  study	  E.	  coli	  due	  to	  its	  
convenience	  and	  thus	  E.	  coli	  growth	  in	  this	  media	  is	  well	  understood	  (Kasina	  et	  al.,	  1999).	  	  
LB	  is	  a	  complex	  media	  made	  up	  of	  yeast	  cell	  lysate,	  peptone,	  and	  salt.	  	  Yeast	  extract	  (YE)	  
and	  potato	  dextrose	  (PD)	  are	  also	  common	  media	  for	  microbial	  growth	  and	  study.	  	  YE	  is	  
composed	  solely	  of	  the	  lysate	  of	  yeast	  cells	  and	  PD	  is	  made	  up	  of	  sliced	  unwashed	  and	  
unpeeled	  potatoes	  combined	  with	  dextrose	  sugar.	  	  LB	  and	  YE	  contain	  all	  of	  the	  components	  
of	  normal	  cells,	  including:	  lipids,	  proteins,	  amino	  acids,	  nucleic	  acids,	  and	  some	  
carbohydrates.	  	  LB	  has	  further	  protein	  content	  in	  the	  form	  of	  added	  peptone.	  	  These	  media	  
provide	  fairly	  diverse	  nutrient	  options;	  however,	  they	  tend	  to	  lack	  simple	  sugars.	  	  In	  
contrast,	  PD	  is	  composed	  of	  only	  starches	  and	  sugars.	  	  This	  protein	  deficient	  environment	  is	  
considerably	  different	  than	  those	  provided	  by	  YE	  and	  LB.	  	  While	  neither	  LB	  nor	  PD	  represent	  
human	  tissues	  to	  a	  more	  accurate	  extent	  than	  LB	  does,	  they	  do	  provide	  differing	  nutrient	  
environments	  in	  which	  to	  observe	  antibiotic	  efficacies	  and	  interactions.	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Materials	  and	  Methods	  
	  
Media	  preparation	  and	  storage:	  Lysogeny	  broth	  (LB),	  yeast	  extract	  (YE),	  and	  potato	  
dextrose	  broth	  (PD)	  were	  prepared	  from	  Fisher	  Scientific-­‐brand	  dehydrated	  powder.	  	  LB	  
powder	  came	  in	  premeasured	  capsules	  that	  were	  dissolved	  in	  1	  L	  milliQ	  water.	  	  23	  g	  YE	  
powder	  and	  10	  g	  NaCl,	  or	  24	  g	  PD	  powder	  and	  10	  g	  NaCl	  were	  dissolved	  in	  1	  L	  milliQ	  water.	  
Media	  was	  sterilized	  and	  stored	  at	  room	  temperature	  in	  sealed	  bottles.	  	  LB	  and	  PD	  broth	  
were	  used	  alone;	  additionally	  a	  combination	  of	  90%	  lysogeny	  and	  10%	  potato	  dextrose	  
broth	  was	  utilized.	  
Table	  1:	  Composition	  of	  various	  media.	  
LB	   10	  g	  peptone	  140,	  5	  g	  yeast	  extract,	  10	  g	  NaCl	  	  
YE	   Extraction	  of	  yeast	  cell	  contents	  
PD	   Sliced	  unwashed	  and	  unpeeled	  potatoes	  and	  dextrose	  
sugar	  
	  
Antibiotic	  preparation	  and	  storage:	  Antibiotics	  were	  prepared	  in	  a	  10	  mg/mL	  
concentration;	  0.1	  g	  streptomycin,	  amikacin,	  and	  tobramycin	  were	  each	  dissolved	  in	  10	  mL	  
milliQ	  water.	  	  0.1	  g	  erythromycin	  was	  dissolved	  in	  10	  mL	  ethanol.	  	  Streptomycin,	  amikacin,	  
and	  erythromycin	  were	  stored	  away	  from	  light	  at	  -­‐37	  degrees	  Celsius.	  	  Tobramycin	  was	  
stored	  away	  from	  light	  at	  -­‐4	  degrees	  Celsius.	  	  New	  antibiotics	  prepared	  monthly	  to	  minimize	  
freeze/thaw	  efficacy	  issues.	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Cell	  culture	  preparation	  and	  storage:	  E.	  coli	  cell	  line,	  Escherichia	  coli	  K-­‐12	  mg1655,	  was	  
stored	  in	  –	  80°C	  freezer	  in	  15%	  glycerol	  solution.	  	  When	  needed,	  single	  aliquot	  was	  removed	  
and	  thawed.	  	  20	  μL	  thawed	  aliquot	  in	  2	  mL	  LB	  broth	  was	  incubated	  for	  4	  to	  6	  hours	  at	  37°C,	  
non-­‐shaking.	  	  Culture	  was	  then	  diluted	  to	  10-­‐4	  concentration	  to	  inoculate	  96	  well	  plate	  
conditions.	  
Basic	  assay	  structure:	  	  Every	  assay	  included:	  negative	  control	  –	  media	  only,	  positive	  control	  
–	  media	  plus	  25	  μL	  of	  10-­‐4	  dilution	  E.	  coli	  culture,	  and	  testing	  conditions.	  	  Testing	  conditions	  
were	  prepared	  by	  combining	  25	  μL	  of	  10-­‐4	  dilution	  E.	  coli	  culture,	  between	  5	  and	  100	  μL	  
antibiotics	  and	  medium	  of	  choice	  to	  bring	  the	  total	  volume	  to	  1	  mL.	  	  100	  μL	  was	  pipetted	  
into	  4	  wells	  of	  a	  Brand	  96	  well	  plate	  for	  each	  condition.	  	  96	  well	  plates	  were	  sealed	  with	  
parafilm,	  wrapped	  in	  tin	  foil,	  and	  placed	  in	  37°C	  incubator	  shaking	  at	  300	  rpm	  for	  18	  hours.	  	  
Determining	  single-­‐drug	  concentrations:	  A	  range	  of	  concentrations	  were	  tested	  for	  each	  
drug.	  	  A	  concentration	  was	  chosen	  that	  reduced	  growth	  rate	  by	  a	  significant	  but	  nonlethal	  
amount	  (approximately	  10-­‐40%	  inhibition).	  
Drug/media	  interaction	  assay:	  	  Streptomycin,	  tobramycin,	  erythromycin	  and	  amikacin	  
were	  assessed	  individually	  and	  in	  a	  pairwise	  fashion	  at	  varying	  doses.	  	  The	  E.	  coli	  dilution	  
remained	  constant	  throughout	  all	  experiments.	  	  These	  experiments	  were	  assessed	  across	  
various	  media.	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pH	  assay:	  40	  μL	  of	  each	  positive	  control	  condition	  (media	  +	  E.	  coli)	  pipetted	  onto	  Fisher	  
Scientific	  pH	  strips	  prior	  to	  96	  well	  plate	  inoculation	  and	  color	  change	  was	  noted	  and	  
recorded.	  	  After	  18	  hours	  and	  plate	  reading,	  40	  μL	  of	  each	  positive	  control	  condition	  
pipetted	  from	  first	  well	  onto	  pH	  strips.	  	  Again	  color	  change	  was	  noted	  and	  recorded.	  
Reading	  plates:	  	  96	  well	  plates	  were	  read	  after	  18	  hours	  of	  incubation	  in	  37°C	  incubator	  
shaking	  at	  300	  rpm.	  	  Plates’	  population	  density	  was	  measured	  with	  VERSA	  max	  microplate	  
reader	  produced	  by	  Molecular	  Devices	  to	  determine	  amount	  of	  bacteria	  present	  in	  each	  
100-­‐µl	  culture.	  	  Optical	  density	  readings	  were	  taken	  at	  wavelength	  600	  after	  shaking	  once	  
and	  testing	  conditions	  were	  compared	  to	  positive	  and	  negative	  controls.	  
Statistics:	  Replicates	  from	  each	  plate	  were	  averaged	  into	  one	  data	  point	  per	  condition	  per	  
plate.	  	  Negative	  control	  (media	  only)	  optical	  density	  was	  subtracted	  from	  positive	  control	  
and	  each	  testing	  condition	  with	  coinciding	  media.	  	  Growth	  in	  testing	  conditions	  was	  then	  
calculated	  as	  percent	  growth	  of	  the	  positive	  control’s	  uninhibited	  growth.	  	  GraphPad	  Prism4	  
statistics	  and	  graphing	  software	  was	  used	  for	  statistical	  analysis	  and	  figure	  generation.	  	  
Specifically	  repeated	  measures	  ANOVA	  was	  used	  to	  assess	  the	  significance	  of	  differences	  in	  
percent	  inhibition	  for	  each	  antibiotic	  individually	  in	  the	  three	  different	  preparations	  of	  
broth	  studied	  at	  different	  concentrations	  of	  antibiotic,	  the	  expected	  additive	  combination	  
value,	  and	  actually	  experimental	  combination	  value.	  	  Tukey’s	  multiple	  comparisons	  test	  was	  
then	  used	  to	  determine	  the	  significance	  of	  specific	  interactions	  therein.	  	  P	  values	  less	  than	  
0.05	  were	  considered	  significant.	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Results	  
In	  order	  to	  begin	  pair-­‐wise	  drug	  interaction	  trials,	  appropriate	  antibiotic	  
concentrations	  for	  each	  drug	  had	  to	  be	  determined	  in	  each	  media.	  	  Experimental	  single	  drug	  
concentrations	  were	  chosen	  that	  decreased	  E.	  coli	  cell	  growth	  by	  a	  significant	  but	  nonlethal	  
amount,	  approximately	  10-­‐40%	  inhibition	  (Fig	  5,	  6,	  7).	  	  This	  range	  was	  crucial	  in	  order	  to	  
differentiate	  between	  synergistic	  and	  additive	  effects.	  	  If	  the	  predicted	  additive	  effect	  was	  
already	  greater	  than	  100%	  inhibition,	  it	  would	  be	  impossible	  to	  distinguish	  synergy.	  	  These	  
drug	  concentrations	  (Table	  2)	  were	  then	  utilized	  in	  the	  experiments	  measuring	  the	  
relationship	  between	  multiple	  antibiotic	  exposures,	  which	  were	  the	  primary	  outcome	  
measure	  for	  this	  research.	  	  Streptomycin	  and	  amikacin	  concentrations	  for	  LB	  media	  were	  
received	  from	  colleague	  Donahey,	  G.,	  from	  unpublished	  data.	  
	  
Figure	  5:	  	  Mean	  ±	  SE	  for	  percent	  inhibition	  for	  various	  antibiotic	  concentrations	  in	  LB	  media	  
(N	  =	  3).	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Figure	  6:	  	  Mean	  ±	  SE	  for	  percent	  inhibition	  for	  various	  antibiotic	  concentrations	  in	  PD	  media	  
(N	  =	  3).	  
	  
Figure	  7:	  	  Mean	  ±	  SE	  for	  percent	  inhibition	  for	  various	  antibiotic	  concentrations	  in	  YE	  media	  
(N	  =	  3).	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Table	  2:	  Antibiotic	  concentrations	  used	  in	  antibiotic	  interaction	  assays.	  
Media	   Antibiotic	   Concentration	  
[μg/mL]	  
LB	   Streptomycin	   2.5	  
Tobramycin	   0.9	  
Erythromycin	   20	  
Amikacin	   0.6	  
PD	   Streptomycin	   25	  
Tobramycin	   9	  
Erythromycin	   200	  
Amikacin	   6	  
YE	   Streptomycin	   5	  
Tobramycin	   5.4	  
Erythromycin	   20	  
Amikacin	   2.4	  
	  
	   E.	  coli	  was	  grown	  in	  96	  well	  plates	  for	  18	  hours	  to	  determine	  the	  efficacy	  and	  
interactions	  between	  streptomycin,	  tobramycin,	  erythromycin,	  and	  amikacin.	  	  Interactions	  
were	  assessed	  in	  LB,	  YE,	  and	  PD	  media	  with	  the	  concentrations	  displayed	  in	  Table	  2.	  	  In	  LB,	  
the	  experimental	  combination	  value	  differed	  from	  the	  expected	  additive	  value	  for	  the	  
combinations	  of	  streptomycin	  and	  tobramycin,	  streptomycin	  and	  amikacin,	  and	  tobramycin	  
and	  amikacin	  (Tukey’s	  Multiple	  Comparison’s	  Test,	  df	  =	  3,2,	  p	  <	  0.05,	  N	  =	  3).	  	  Each	  of	  these	  
combinations	  showed	  synergistic	  interactions,	  where	  combination	  treatment	  inhibited	  
almost	  twice	  as	  much	  as	  would	  be	  expected	  if	  the	  effects	  were	  additive.	  	  The	  combinations	  
of	  erythromycin	  with	  each	  of	  the	  other	  three	  antibiotics	  provided	  experimental	  values	  were	  
less	  than	  the	  additive	  in	  each	  case;	  however,	  these	  effects	  were	  not	  significant	  (Figure	  8).	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Figure	  8:	  Mean	  ±	  SE	  for	  percent	  inhibition	  of	  antibiotics	  individually,	  and	  in	  pairwise	  
combinations,	  in	  LB	  media.	  	  The	  additive	  bar	  is	  what	  would	  be	  anticipated	  to	  occur,	  if	  the	  
two	  antibiotics	  studied	  worked	  via	  an	  additive	  interaction,	  and	  is	  a	  calculated	  measure.	  	  The	  
experimental	  bar	  on	  the	  far	  right	  is	  the	  experimental	  value	  obtained	  when	  the	  two	  
antibiotics	  were	  placed	  together	  in	  media.	  	  Green	  bar	  represents	  a	  synergistic	  interaction	  
and	  purple	  an	  additive	  interaction.	  	  S	  stands	  for	  streptomycin,	  T	  for	  tobramycin,	  E	  for	  
erythromycin,	  and	  A	  for	  amikacin	  (N=3	  plates	  with	  4	  wells	  each).	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In	  YE,	  the	  combinations	  of	  amikacin	  with	  both	  streptomycin	  and	  tobramycin	  had	  
significantly	  greater	  experimental	  inhibition	  than	  would	  be	  expected	  if	  the	  effects	  were	  
additive	  (Tukey’s	  Multiple	  Comparison’s	  Test,	  df	  =	  3,2,	  p	  <	  0.001,	  N	  =	  3),	  showing	  synergistic	  
interactions.	  	  In	  addition,	  the	  combination	  of	  amikacin	  and	  erythromycin	  had	  significantly	  
less	  experimental	  inhibition	  than	  would	  be	  expected	  if	  the	  effects	  were	  additive	  (Tukey’s	  
Multiple	  Comparison’s	  Test,	  df	  =	  3,2,	  p	  <	  0.05,	  N	  =	  3),	  exhibiting	  an	  antagonistic	  interaction.	  	  
This	  antagonistic	  interaction	  can	  be	  further	  classified	  as	  antagonistic	  buffering	  as	  the	  
experimental	  combination	  value	  does	  not	  differ	  significantly	  from	  either	  antibiotic	  alone	  
(Tukey’s	  Multiple	  Comparison’s	  Test,	  df	  =	  3,2,	  p	  >	  0.05,	  N	  =	  3).	  	  The	  combinations	  of	  
streptomycin	  and	  tobramycin	  as	  well	  as	  erythromycin	  with	  both	  streptomycin	  and	  
tobramycin	  provided	  experimental	  values	  were	  less	  than	  the	  additive	  in	  each	  case;	  
however,	  these	  effects	  were	  not	  significant	  (Figure	  9).	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Figure	  9:	  Mean	  ±	  SE	  for	  percent	  inhibition	  of	  antibiotics	  individually,	  and	  in	  pairwise	  
combinations,	  in	  YE.	  	  The	  experimental	  bar	  on	  the	  far	  right	  is	  the	  experimental	  value	  
obtained	  when	  the	  two	  antibiotics	  were	  placed	  together	  in	  media.	  	  Green	  bar	  represents	  a	  
synergistic	  interaction,	  purple	  an	  additive	  interaction,	  and	  red	  an	  antagonistic	  interaction.	  	  S	  
stands	  for	  streptomycin,	  T	  for	  tobramycin,	  E	  for	  erythromycin,	  and	  A	  for	  amikacin	  (N=3	  
plates	  with	  4	  wells	  each).	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The	  concentration	  of	  antibiotics	  used	  in	  PD	  testing	  was	  10	  times	  that	  used	  in	  LB	  
conditions.	  	  Although	  these	  concentrations	  achieved	  the	  desired	  inhibition	  during	  the	  
previously	  performed	  antibiotic	  concentration	  determination	  assays,	  these	  results	  were	  not	  
seen	  in	  the	  antibiotic	  interaction	  assay.	  	  In	  contrast,	  E.	  coli	  grown	  in	  PD	  showed	  little	  to	  no	  
inhibition	  due	  to	  any	  of	  the	  antibiotics.	  	  There	  were	  no	  significant	  differences	  between	  the	  
experimental	  combination	  inhibition	  and	  the	  expected	  additive	  inhibition	  in	  PD	  (Repeated	  
Measures	  ANOVA,	  df	  =	  3,2,	  p	  >	  0.05,	  N	  =	  3).	  	  As	  such,	  all	  interactions	  were	  additive	  (Figure	  
10).	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Figure	  10:	  Mean	  ±	  SE	  for	  percent	  inhibition	  of	  antibiotics	  individually,	  and	  in	  pairwise	  
combinations,	  in	  PD.	  	  The	  experimental	  bar	  on	  the	  far	  right	  is	  the	  experimental	  value	  
obtained	  when	  the	  two	  antibiotics	  were	  placed	  together	  in	  media.	  	  Green	  bar	  represents	  a	  
synergistic	  interaction,	  purple	  an	  additive	  interaction,	  and	  red	  an	  antagonistic	  interaction.	  	  S	  
stands	  for	  streptomycin,	  T	  for	  tobramycin,	  E	  for	  erythromycin,	  and	  A	  for	  amikacin	  (N=3	  
plates	  with	  4	  wells	  each).	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   Antibiotics	  were	  not	  equally	  effective	  in	  all	  media	  types	  (Figure	  11).	  	  E.	  coli	  grown	  in	  
PD	  media,	  in	  particular,	  showed	  extremely	  high	  tolerance	  to	  antibiotic	  inhibition.	  
	  
Figure	  11:	  Antibiotic	  concentrations	  used	  in	  antibiotic	  interaction	  assays.	  	  Orange	  bars	  
represent	  concentrations	  for	  LB	  media,	  yellow	  bars	  are	  for	  PD	  media,	  and	  pink	  bars	  are	  for	  
YE	  media.	  	  	  
	   It	  was	  noted	  that	  the	  overall	  uninhibited	  growth	  in	  LB	  and	  YE	  seemed	  to	  be	  greater	  
than	  that	  in	  PD.	  	  To	  determine	  whether	  the	  increased	  tolerance	  seen	  in	  PD	  media	  was	  the	  
result	  of	  this	  overall	  deceleration	  in	  cellular	  growth	  or	  to	  the	  nutritional	  contents	  of	  PD	  
media,	  LB	  was	  diluted	  with	  PD	  at	  intervals	  of	  10%.	  	  If	  the	  antibiotic	  tolerance	  was	  based	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solely	  on	  the	  decreased	  growth	  rate	  in	  PD	  media,	  we	  would	  expect	  high	  levels	  of	  tolerance	  
to	  coincide	  with	  a	  dilution	  that	  exhibited	  significant	  reduction	  in	  growth	  rate.	  	  However,	  if	  
this	  tolerance	  was	  instead	  dependent	  on	  other	  factors	  having	  to	  do	  with	  the	  composition	  of	  
PD	  media,	  we	  could	  see	  signs	  of	  tolerance	  at	  any	  dilution.	  
When	  100%	  PD	  was	  compared	  to	  100%	  LB	  in	  this	  follow-­‐up	  study,	  the	  overall	  
uninhibited	  growth	  was,	  in	  fact,	  significantly	  less	  than	  that	  in	  LB	  media	  (Tukey’s	  Multiple	  
Comparison’s	  Test,	  df	  =	  3,2,	  p	  <	  0.0001,	  N	  =	  3).	  	  Uninhibited	  growth	  differed	  significantly	  
between	  100%	  LB	  media	  at	  every	  dilution	  (Tukey’s	  Multiple	  Comparison’s	  Test,	  df	  =	  3,2,	  p	  <	  
0.05,	  N	  =	  3,	  Figure	  12	  A).	  	  Antibiotic	  concentrations	  used	  in	  this	  assay	  were	  four	  times	  those	  
used	  in	  the	  100%	  LB	  assay.	  	  Inhibition	  due	  to	  streptomycin	  was	  less	  than	  that	  at	  100%	  LB	  for	  
each	  dilution;	  however,	  the	  decrease	  was	  not	  significant	  until	  50%	  LB/50%	  PD	  media	  
(Tukey’s	  Multiple	  Comparison’s	  Test,	  df	  =	  3,2,	  p	  <	  0.05,	  N	  =	  3).	  	  Inhibition	  due	  to	  
streptomycin	  and	  tobramycin	  was	  less	  than	  that	  at	  100%	  LB	  for	  each	  dilution;	  however,	  the	  
decreases	  were	  not	  significant	  until	  50%	  LB/50%	  PD	  media	  (Tukey’s	  Multiple	  Comparison’s	  
Test,	  df	  =	  3,2,	  p	  <	  0.05,	  N	  =	  3).	  	  Inhibition	  due	  to	  erythromycin	  was	  significantly	  less	  than	  
that	  at	  100%	  LB	  for	  every	  dilution	  (Tukey’s	  Multiple	  Comparison’s	  Test,	  df	  =	  3,2,	  p	  <	  0.001,	  N	  
=	  3).	  	  Inhibition	  due	  to	  amikacin	  was	  less	  than	  that	  at	  100%	  LB	  for	  each	  dilution;	  however,	  
the	  decreases	  were	  only	  significant	  for	  60%	  LB/40%	  PD,	  40%	  LB/60%	  PD,	  and	  20%	  LB/80%	  
PD	  media	  (Tukey’s	  Multiple	  Comparison’s	  Test,	  df	  =	  3,2,	  p	  <	  0.05,	  N	  =	  3,	  Figure	  12	  B).	  	  
Although	  the	  first	  signs	  of	  significant	  tolerance	  did	  not	  appear	  to	  coincide	  with	  a	  major	  
decrease	  in	  uninhibited	  growth,	  which	  would	  point	  towards	  media	  components	  being	  the	  
larger	  contributing	  factor,	  these	  data	  were	  not	  satisfactorily	  conclusive.	  	  	  
	  	   35	  
	  
Figure	  12:	  A:	  Mean	  ±	  SE	  for	  uninhibited	  growth	  in	  positive	  controls	  for	  dilutions	  of	  LB	  with	  
PD.	  	  B:	  Mean	  ±	  SE	  for	  percent	  inhibition	  under	  testing	  conditions	  with	  each	  antibiotic	  for	  
dilutions	  of	  LB	  with	  PD	  (N=3	  plates	  with	  4	  wells	  each).	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   Starting	  and	  final	  pH	  was	  noted	  to	  track	  changes	  made	  throughout	  incubation	  to	  get	  
an	  increased	  idea	  of	  E.	  coli’s	  active	  metabolic	  processes	  therein.	  	  Many	  metabolic	  pathways	  
have	  specific	  byproducts	  that	  are	  excreted	  into	  the	  environment	  and	  effect	  pH,	  such	  as,	  the	  
catabolism	  of	  proteins,	  which	  releases	  basic	  byproducts	  that	  increase	  pH	  (Burstain	  et	  al.,	  
2003)).	  	  Starting	  pH	  for	  LB,	  YE,	  and	  90%	  LB/10%	  PD	  media	  was	  relatively	  similar	  and	  almost	  
neutral,	  at	  approximately	  pH	  6.	  	  It	  was	  discovered	  that	  the	  starting	  pH	  of	  PD	  media,	  
approximately	  4,	  was	  more	  acidic.	  	  Final	  pH	  increased	  for	  LB,	  YE,	  and	  90%	  LB/10%	  PD	  media,	  
but	  remained	  constant	  for	  PD	  media,	  as	  well	  as,	  remaining	  constant,	  or	  even	  decreasing,	  for	  
all	  other	  dilutions.	  	  This	  suggests	  protein	  breakdown	  was	  occurring	  in	  the	  LB,	  YE,	  and	  90%	  
LB/10%	  PD	  but	  not	  in	  PD	  or	  any	  other	  dilutions.	  For	  specifics	  see	  Table	  3.	  	  
Table	  3.	  Starting	  and	  final	  pH	  data	  for	  all	  media	  types	  used	  in	  this	  experiment.	  
Condition	  	   Starting	  pH	   Final	  pH	  
100%	  LB	   6	   7	  
YE	   6.5	   8	  
100%	  PD	   4	   4	  
90%	  LB/10%	  PD	   6	   7	  
80%	  LB/20%	  PD	   5	   4.5	  
70%	  LB/30%	  PD	   5	   4.5	  
60%	  LB/40%	  PD	   5	   4.5	  
50%	  LB/50%	  PD	   5	   4	  
40%	  LB/60%	  PD	   5	   4	  
30%	  LB/70%	  PD	   4.5	   4	  
20%	  LB/80%	  PD	   4	   4	  
10%	  LB/90%	  PD	   4	   4	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   In	  order	  to	  further	  parse	  out	  the	  effects	  of	  media	  nutrient	  conditions,	  overall	  growth	  
rate,	  and	  pH,	  drug	  interaction	  assays	  were	  run	  using	  90%	  LB/10%	  PD.	  	  90%	  LB/10%	  PD	  
media	  most	  closely	  resembled	  LB,	  our	  control	  media.	  	  Although	  90%	  LB/10%	  PD	  had	  
significantly	  less	  growth	  than	  100%	  LB,	  its	  growth	  was	  much	  more	  similar	  to	  that	  of	  100%	  LB	  
than	  to	  that	  of	  100%	  PD.	  	  In	  addition,	  its	  starting	  and	  final	  pH’s	  were	  identical	  to	  those	  of	  
100%	  LB.	  	  The	  antibiotic	  concentrations	  used	  in	  this	  antibiotic	  interaction	  assay	  were	  twice	  
the	  antibiotic	  concentrations	  used	  in	  LB	  tests.	  	  The	  experimental	  combination	  value	  differed	  
from	  the	  expected	  additive	  value	  for	  the	  combinations	  of	  amikacin	  with	  each	  other	  
antibiotic	  (Tukey’s	  Multiple	  Comparison’s	  Test,	  df	  =	  3,2,	  p	  <	  0.05,	  N	  =	  3).	  	  Each	  of	  these	  
combinations	  showed	  synergistic	  interactions	  where	  combination	  treatment	  inhibited	  up	  to	  
about	  five	  times	  as	  much	  as	  would	  be	  expected	  if	  the	  effects	  were	  additive.	  	  While	  the	  
combination	  of	  streptomycin	  and	  tobramycin	  produced	  experimental	  inhibition	  that	  was	  
greater	  than	  expected	  if	  the	  effects	  were	  additive,	  this	  effect	  was	  not	  significant.	  	  The	  
combinations	  of	  streptomycin	  and	  erythromycin	  and	  tobramycin	  and	  erythromycin	  
produced	  experimental	  values	  that	  were	  less	  than	  the	  additive	  in	  both	  cases,	  but	  these	  
effects	  were	  again	  not	  statistically	  significant	  (Figure	  13).	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Figure	  13:	  Mean	  ±	  SE	  for	  percent	  inhibition	  of	  antibiotics	  individually,	  and	  in	  pairwise	  
combinations,	  in	  90%	  LB	  and	  10%	  PD	  media.	  	  The	  additive	  bar	  is	  what	  would	  be	  anticipated	  
to	  occur,	  if	  the	  two	  antibiotics	  studied	  worked	  via	  an	  additive	  interaction,	  and	  is	  a	  calculated	  
measure.	  	  The	  experimental	  bar	  on	  the	  far	  right	  is	  the	  experimental	  value	  obtained	  when	  
the	  two	  antibiotics	  were	  placed	  together	  in	  media.	  	  Green	  bar	  represents	  a	  synergistic	  
interaction,	  purple	  an	  additive	  interaction,	  and	  red	  an	  antagonistic	  interaction.	  	  S	  stands	  for	  
streptomycin,	  T	  for	  tobramycin,	  E	  for	  erythromycin,	  and	  A	  for	  amikacin	  (N=3	  plates	  with	  4	  
wells	  each).	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   Some	  of	  the	  interactions	  between	  tested	  pairs	  of	  antibiotics	  differed	  with	  media	  and	  
others	  remained	  constant	  (Table	  4).	  
Table	  4:	  Antibiotic	  interactions	  for	  all	  tested	  pairs	  in	  each	  type	  of	  media.	  	  S	  stands	  for	  
streptomycin,	  T	  for	  tobramycin,	  E	  for	  erythromycin,	  and	  A	  for	  amikacin.	  Syn	  stands	  for	  
synergistic,	  Add	  for	  additive,	  and	  Ant	  for	  antagonistic.	  
Antibiotic	  
combination	  
LB	   YE	   PD	   90%	  LB/10%	  PD	  
S+T	   Syn	   Add	   Add	   Add	  
S+E	   Add	   Add	   Add	   Add	  
S+A	   Syn	   Syn	   Add	   Syn	  
T+E	   Add	   Add	   Add	   Add	  
T+A	   Syn	   Syn	   Add	   Syn	  
E+A	   Add	   Ant	   Add	   Syn	  
	  
Discussion	  
We	  found	  that	  at	  least	  some	  antibiotic	  efficacies	  and	  interactions	  appear	  to	  be	  
dependent	  on	  the	  environmental	  nutrient	  conditions	  E.	  coli	  is	  grown	  in	  (Figure	  11	  &	  Table	  
4).	  	  The	  differences	  in	  antibiotic	  efficacies	  are	  most	  apparent	  when	  comparing	  LB	  and	  PD	  
media	  (Figure	  11).	  	  The	  antibiotic	  concentrations	  used	  in	  PD	  were	  10	  times	  those	  used	  in	  LB,	  
and	  even	  with	  such	  high	  concentrations	  inhibition	  was	  minimal	  and	  inconsistent	  (Figures	  5	  
&	  10.	  	  When	  studying	  the	  YE	  results	  tolerance	  appears	  more	  varied	  between	  the	  antibiotics	  
tested	  (Figure	  11).	  	  Tolerance	  was	  relatively	  high	  for	  amikacin	  (four	  times	  that	  of	  LB)	  and	  
tobramycin	  (six	  times	  that	  of	  LB),	  but	  relatively	  low	  for	  streptomycin	  (twice	  that	  of	  LB)	  and	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erythromycin	  (the	  same	  as	  LB).	  	  In	  addition,	  LB,	  YE	  and	  PD	  each	  showed	  varied	  antibiotic	  
interactions	  for	  at	  least	  one	  drug	  interaction	  (Table	  4).	  	  	  
There	  could	  be	  several	  causes	  for	  the	  observed	  discrepancies	  between	  media.	  	  The	  
first	  is	  the	  apparent	  slowed	  uninhibited	  growth	  rate	  in	  PD	  when	  compared	  to	  LB	  or	  YE	  
(Figure	  12).	  	  The	  antibiotics	  studied	  here	  bind	  to	  the	  ribosome	  and	  inhibit	  protein	  synthesis.	  	  
As	  such,	  it	  would	  make	  sense	  for	  E.	  coli	  exhibiting	  slower	  growth	  rates	  to	  show	  less	  
inhibition,	  as	  slower	  growth	  rates	  are	  indicative	  of	  less	  protein	  synthesis.	  	  This	  leaves	  our	  
antibiotics	  with	  fewer	  protein	  synthesizing	  ribosome	  targets	  to	  inhibit	  (Amato	  et	  al,	  2015).	  	  
This	  seems	  like	  an	  unlikely	  primary	  cause;	  however,	  because	  E.	  coli	  grown	  in	  YE	  and	  LB	  
respectively	  had	  very	  similar	  uninhibited	  growth	  but	  expressed	  different	  antibiotic	  
tolerances	  and	  different	  antibiotic	  interactions.	  	  In	  addition,	  as	  noted	  previously,	  during	  the	  
serial	  dilutions	  experiment	  (Figure	  12),	  increases	  in	  tolerance	  did	  not	  correspond	  to	  a	  large	  
decrease	  in	  uninhibited	  growth.	  	  This	  suggests	  that	  something	  other	  than	  growth	  rate	  is	  
affecting	  tolerance.	  	  Finally,	  90%	  LB/10%	  PD	  had	  similar	  uninhibited	  growth	  to	  LB,	  
approximately	  80%	  growth	  compared	  to	  LB’s,	  and	  more	  than	  three	  times	  the	  uninhibited	  
growth	  of	  PD	  (Figure	  12).	  	  While	  the	  interactions	  in	  this	  hybrid	  media	  more	  closely	  resemble	  
those	  in	  LB	  than	  PD,	  the	  interaction	  between	  streptomycin	  and	  tobramycin	  differed	  (Table	  
4)	  and	  E.	  coli	  grown	  in	  this	  media	  showed	  increased	  antibiotic	  tolerance,	  particularly	  for	  
erythromycin	  and	  amikacin	  (Figure	  12).	  
The	  second	  possible	  contributing	  factor	  is	  the	  differences	  in	  pH	  observed	  between	  
the	  media	  types.	  	  The	  most	  drastic	  of	  which	  is	  PD’s	  relatively	  acidic	  pH	  when	  compared	  to	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the	  relatively	  neutral	  pHs	  of	  LB	  and	  YE	  (Table	  3).	  	  It	  is	  understood	  that	  pH	  plays	  a	  significant	  
role	  in	  both	  enzyme	  activity	  and	  overall	  cellular	  growth	  (Gale	  &	  Epps,	  1945;	  Conner	  &	  
Toltrola,	  1995).	  	  Thus,	  these	  discrepancies	  in	  starting	  pH	  could	  be	  a	  major	  contributing	  
factor	  for	  the	  observed	  variations.	  	  In	  addition,	  the	  final	  pH	  of	  LB	  and	  YE	  was	  greater	  than	  
that	  of	  the	  starting	  pH.	  	  As	  this	  is	  an	  indicator	  of	  protein	  catabolism,	  it	  reveals	  this	  metabolic	  
process	  could	  be	  active	  in	  E.	  coli	  grown	  in	  LB	  and	  YE,	  while	  the	  lack	  of	  pH	  change	  in	  PD	  
suggests	  protein	  catabolism	  is	  not	  occurring	  therein.	  	  This	  is	  an	  attractive	  option	  as	  a	  
contributing	  factor	  but	  is	  probably	  not	  the	  soul	  contributor.	  	  90%	  LB/10%	  PD	  had	  identical	  
starting	  and	  final	  pHs	  to	  LB	  but	  still	  showed	  signs	  of	  increased	  tolerance	  (Figure	  12)	  this	  
indicates	  that	  at	  least	  some	  of	  this	  change	  is	  due	  to	  something	  other	  than	  pH.	  	  It	  does	  
appear	  that	  the	  synergistic	  interactions	  between	  amikacin	  and	  both	  streptomycin	  and	  
tobramycin	  were	  restored	  in	  90%	  LB/10%	  PD	  as	  opposed	  to	  PD	  alone;	  however,	  the	  synergy	  
between	  streptomycin	  and	  tobramycin	  was	  not	  restored	  and	  a	  novel	  synergy	  between	  
erythromycin	  and	  amikacin	  was	  observed	  (Table	  4).	  	  In	  addition,	  YE	  also	  had	  a	  very	  similar	  
starting	  and	  final	  pH	  to	  LB	  and	  showed	  similar	  increases	  in	  pH	  throughout	  incubation	  (Table	  
4),	  suggesting	  a	  comparable	  amount	  of	  protein	  catabolism.	  	  However,	  it	  too	  showed	  
antibiotic	  interactions	  (Table	  4)	  and	  efficacies	  (Figure	  11)	  that	  varied	  from	  those	  in	  LB.	  	  Thus,	  
it	  appears	  neither	  starting	  pH,	  nor	  the	  presence	  of	  active	  protein	  break	  down	  is	  solely	  
responsible	  for	  the	  observed	  variations	  between	  media	  types.	  	  
The	  remaining	  difference	  between	  the	  media,	  that	  could	  be	  culpable,	  is	  differences	  
in	  the	  nutritional	  content	  of	  these	  media.	  	  Although	  YE	  and	  LB	  are	  extremely	  similar	  media,	  
containing	  yeast	  cell	  lysate	  i.e.,	  lipids,	  proteins,	  amino	  acids,	  nucleic	  acids,	  carbohydrates	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etc.,	  LB	  has	  added	  protein	  in	  the	  form	  of	  peptone.	  	  In	  contrast,	  PD	  is	  made	  up	  almost	  
entirely	  of	  sugars	  and	  starches.	  	  Thus,	  differences	  between	  these	  media	  can	  be	  looked	  at	  in	  
the	  form	  of	  deficiencies	  or	  richness.	  	  LB	  and	  YE	  are	  rich	  in	  protein	  and	  many	  other	  nutrients,	  
including:	  lipids	  and	  nucleic	  acids,	  but	  deficient	  in	  sugars,	  while	  PD	  is	  rich	  in	  sugars	  but	  
deficient	  in	  just	  about	  every	  other	  nutrient.	  	  It	  is	  possible	  that	  either	  the	  presence	  or	  the	  
absence	  of	  metabolites	  could	  be	  responsible	  for	  the	  variation	  in	  antibiotic	  efficacies	  and	  
interactions.	  
Sugar	  and	  nitrogen	  starvation	  are	  both	  serious	  environmental	  stressors	  for	  E.	  coli.	  	  
Reactions	  to	  these	  different	  starvation	  conditions	  trigger	  the	  activation	  of	  different	  genes,	  
leading	  to	  vastly	  different	  transcription	  panels	  and	  highly	  nuanced	  responses	  to	  these	  
different,	  but	  similar,	  threats	  (Hua	  et	  al.	  2004).	  	  In	  addition	  to	  changes	  in	  overall	  gene	  
transcription,	  very	  specific	  stress	  response	  pathways	  are	  activated	  by	  starvation.	  	  Some	  of	  
these	  pathways	  include	  the	  triacylglycerol	  (TAG)	  and	  stringent	  (SR)	  responses	  (White,	  2007).	  	  
The	  TAG	  response	  is	  activated	  by	  changes	  in	  cellular	  carbon	  fluxes	  (Sedwick,	  2011,	  White,	  
2007).	  	  It	  initiates	  the	  preparation	  for	  and	  entry	  into	  a	  state	  of	  cellular	  inactivity	  (Baek	  et	  al.,	  
2015).	  	  In	  this	  state,	  little	  to	  no	  growth	  occurs	  and	  cells	  suppress	  metabolic	  activity.	  	  The	  SR	  
response	  is	  a	  common	  bacterial	  response	  to	  carbon,	  amino	  acid,	  and	  iron	  starvation	  (White,	  
2007,	  Nguyen	  et	  al.,	  2011).	  	  In	  contrast	  to	  the	  reduced	  activity	  triggered	  by	  the	  TAG	  
response,	  the	  SR	  response	  leads	  to	  the	  reallocation	  of	  cellular	  resources	  to	  increase	  protein	  
synthesis	  of	  factors	  crucial	  for	  stress	  resistance,	  glycolysis,	  and	  amino	  acid	  synthesis	  at	  the	  
expense	  of	  the	  production	  of	  DNA,	  stable	  RNA,	  ribosomal	  proteins,	  and	  membrane	  
components	  (Dalebroux	  &	  Swanson,	  2012).	  	  Previous	  studies	  suggest	  that	  nitrogen	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starvation,	  in	  particular,	  can	  lead	  to	  increased	  tolerance	  to	  many	  harmful	  environmental	  
factors,	  including	  antibiotics.	  	  This	  is	  achieved	  by	  the	  slowing	  of	  protein	  synthesis,	  because	  if	  
no	  amino-­‐acid	  building	  blocks	  are	  present,	  the	  cell	  cannot	  synthesize	  proteins	  (Nguyen	  et	  
al.,	  2011;	  Bernier	  et	  al.,	  2015;	  Penesyan	  et	  al.,	  2015;	  Prax	  &	  Bertram,	  2014;	  Cho	  et	  al,	  2014;	  
Amato	  et	  al.,	  2014).	  	  	  
The	  metabolism	  of	  sugars	  and	  starches	  varies	  immensely	  from	  the	  metabolism	  of	  
proteins	  and	  amino	  acids	  (White,	  2007;	  Slonczewski	  &	  Foster,	  2011).	  	  These	  differences	  in	  
metabolism	  could	  be	  responsible	  for	  the	  variations	  between	  PD	  and	  both	  LB	  and	  YE	  
observed	  in	  this	  study.	  	  The	  differences	  between	  LB	  and	  YE	  were	  more	  surprising	  due	  to	  
their	  relative	  similarity	  in	  nutritional	  content;	  however,	  metabolic	  processes	  are	  exceedingly	  
complicated	  and	  it	  is	  possible	  that	  E.	  coli	  grown	  in	  YE	  have	  vastly	  different	  metabolic	  profiles	  
than	  those	  grown	  in	  LB.	  	  If	  this	  were	  the	  case,	  underlying	  metabolism	  could	  be	  a	  prominent	  
contributor	  to	  the	  observed	  changes	  in	  antibiotic	  efficacy	  and	  interaction.	  	  In	  addition,	  
bacteria	  have	  extensive	  networks	  in	  place	  that	  sense	  their	  environments.	  	  These	  
complicated	  sensory	  mechanisms	  activate	  pathways	  that	  produce	  changes	  in	  bacterial	  gene	  
regulation,	  proteome,	  metabolism,	  physiology	  and	  behavior	  (Szurmant	  &	  Ordal,	  2004).	  	  
Because	  differences	  in	  antibiotic	  interactions	  and	  efficacies	  exist	  between	  90%	  LB/10%	  PD,	  
it	  is	  possible	  that	  something	  in	  the	  PD	  media,	  most	  likely	  sugar,	  is	  acting	  as	  a	  signaling	  
molecule.	  	  With	  such	  a	  small	  dilution	  between	  100%	  LB	  and	  90%	  LB,	  it	  would	  seem	  unlikely	  
that	  the	  media	  is	  missing	  much	  of	  what	  is	  present	  in	  LB.	  	  Additionally,	  pH	  values	  indicate	  
that	  protein	  catabolism	  is	  occurring	  in	  both	  90%	  LB/10%	  PD	  and	  100%	  LB	  making	  protein	  
starvation	  an	  unlikely	  explanation	  for	  the	  variations	  between	  the	  two;	  however,	  even	  a	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small	  addition	  of	  sugar	  could	  cause	  significant	  changes	  if	  it	  were	  a	  signaling	  molecule.	  	  If	  this	  
turned	  out	  to	  be	  the	  case,	  it	  is	  unclear	  why	  the	  detection	  of	  sugar	  would	  lead	  to	  changes	  
that	  result	  in	  increased	  antibiotic	  tolerance,	  as	  it	  would	  be	  expected	  that	  sugar	  would	  
simply	  be	  used	  as	  a	  nutritional	  source	  and	  not	  an	  indicator	  of	  stressful	  conditions.	  
Although	  discrepancies	  in	  antibiotic	  efficacies	  and	  interactions	  were	  noted	  in	  this	  
study	  and	  conjectures	  were	  made	  regarding	  their	  causes,	  more	  research	  would	  need	  to	  be	  
performed	  to	  truly	  understand	  the	  mechanisms	  underlying	  these	  changes.	  	  In	  order	  to	  
continue	  parsing	  out	  the	  differences	  between	  the	  media	  studied	  here,	  I	  would	  start	  with	  PD	  
media	  and	  try	  to	  run	  similar	  experiments	  while	  controlling	  pH.	  	  If	  results	  were	  the	  same	  as	  
seen	  here,	  further	  work	  could	  be	  done	  looking	  into	  the	  effects	  of	  adding	  proteins	  into	  this	  
media.	  	  It	  would	  also	  be	  interesting	  to	  dilute	  YE	  with	  PD	  in	  order	  to	  see	  if	  this	  produced	  
similar	  results	  to	  the	  dilutions	  of	  LB	  with	  PD.	  	  However,	  the	  use	  of	  fully	  defined	  minimal	  
media	  would	  allow	  for	  the	  best	  tracking	  of	  specific	  changes	  in	  nutrition.	  	  Once	  a	  specific	  
metabolite	  is	  identified	  as	  either	  a	  trigger	  for	  tolerance	  or	  changed	  interaction,	  E.	  coli	  
mutants,	  deficient	  in	  certain	  metabolic	  processes,	  could	  be	  used	  to	  further	  understand	  the	  
effects	  of	  underlying	  active	  metabolic	  pathways.	  	  In	  addition,	  YE	  and	  PD	  media	  were	  
explored	  in	  this	  study	  and	  while	  they	  were	  useful	  in	  identifying	  media’s	  effect	  on	  antibiotic	  
efficacy	  and	  interactions,	  they	  do	  not	  reflect	  human	  tissues	  any	  more	  accurately	  than	  LB.	  	  In	  
order	  to	  get	  the	  most	  clinically	  relevant	  data,	  experiments	  should	  be	  run	  in	  media	  that	  best	  
approximates	  human	  tissues.	  	  The	  easiest	  of	  these	  might	  achieve	  might	  be	  blood	  as	  it	  is	  
already	  liquid	  and	  could	  easily	  be	  adapted	  as	  a	  growth	  medium.	  	  However,	  because	  E.	  coli	  
most	  often	  causes	  infections	  of	  the	  urinary	  and	  digestive	  tracts,	  it	  might	  be	  worthwhile	  to	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create	  media	  with	  the	  same	  components	  as	  are	  found	  in	  these	  locations.	  	  These	  next	  steps	  
are	  crucial	  for	  the	  increased	  understanding	  of	  antibiotics	  and	  their	  interactions	  and	  for	  
responsible	  patient	  care.	  	  	  
These	  findings	  could	  have	  serious	  implications	  for	  use	  of	  drug	  combinations	  as	  drug	  
treatments.	  	  Not	  all	  microenvironments	  within	  the	  human	  body	  have	  identical	  nutrient	  
make-­‐up.	  	  If	  the	  interactions	  antibiotics	  are	  reported	  to	  have	  in	  one	  environmental	  
condition	  change	  under	  another,	  reckless	  prescription	  of	  combinations	  could	  lead	  to	  a	  
serious	  adverse	  reaction.	  	  Further	  research	  is	  necessary	  to	  more	  fully	  understand	  antibiotic	  
interactions	  and	  antibiotics	  in	  general.	  	  This	  study	  only	  slightly	  scratched	  the	  surface	  by	  
manipulating	  nutritional	  content.	  	  Every	  other	  environmental	  factor	  that	  triggers	  bacterial	  
stress	  responses,	  effects	  growth,	  or	  changes	  bacterial	  metabolism	  could	  have	  an	  effect	  on	  
antibiotic	  efficacy	  and	  interactions	  that	  are	  currently	  taken	  for	  granted.	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